Hepatitis due to Nitrofurantoin. L Mollison, P Angus, RM Jones.  M.J.A. 156(5), 347 - 349 (1992)

​

Cure of Rhizopus sinusitis in a liver transplant recipient with liposomal amphotericin B.  Monkhouse, RM Jones, FA Tosolini, A Marzec, Angus PW, ML Grayson. Clinical Infectious Disease 16:183  1993)

 

High dose oral acyclovir reduces the incidence of CMV infection in Liver Transplant recipients. L Mollison, MJ Richards, Johnson P, Hayes K, PW Angus, Jones RM, Munckhof W,  Dabkowski P. Journal of Infectious Disease 168(3), 721 - 724 (1993)

​

Combination antiviral therapy controls severe post -  liver transplant recurrence of Hepatitis B infection. P Angus, Richards M, Bowden S, Ireton J, Sinclair R, Jones R,  Lochinini S.  Journal of Gastr & Hepatol 1993, 8 : 353-357 

​

Endotoxin and tumour necrosis factor levels and haemodynamics during human liver transplantation. PL McNicol, G Liu, A Shulkes, KJ Hardy, RM Jones. Trans Proc 25:2. 1828 - 1829. 1993

 

Liposomal amphotericin therapy and cure of Rhizopus sinusitis in a liver transplant recipient.  Munckhof W, Jones RM, Tosolini FA, Marzec A, Angus PW, Grayson ML.  Clinical Infectious Disease 1993; 16: 183

​

Lymphoproliferative disease of donor origin arising in Patients after Orthotopic liver Transplantation . Armes J, Angus P, Southey M, Battaglia, Ross B, Jones R, Venter  Cancer 74(9), 2436-2441  (1994)

​

Hepatic artery anatomy in relation to reconstruction in liver transplantation: some unusual variations. Hardy KJ, Jones RM.Aust N Z J Surg. 1994 Jun;64(6):437-40.

​

Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Angus PW, Locarnini, McGaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatology 31(1), 14 - 18 (1995)

 

Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection. Moaven LD, Locarnini SA, Bowden DS, Kim JP, Breschkin A, McCaw R, Yun A, Wages J Jr, Jones B, Angus P.  J Hepatol. 1997 Oct;27(4):613-9.

​

Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. McCaughan GW, Spencer J, Koorey D, Bowden S, Bartholomeusz A, Littlejohn M, Verran D, Chui AK, Sheil AG, Jones RM, Locarnini SA, Angus PW.

Liver Transpl Surg. 1999 Nov;5(6):512-9.

​

Hydatid disease invading the inferior vena cava: successful combined medical and surgical treatment. :Karunajeewa HA, Jones RM, Hardy KJ, Buxton BF, Richards MJ. ANZ J Surg. 2002 Feb;72(2):159-60.

​

The use of a composite graft of iliac artery and inferior mesenteric vein in liver transplantation.  Fink MA, Jones RM. Transpl Int. 2006 Jan;19(1):81-3.  PubMed PMID: 16359381.

 

Risk factors for liver transplantation waiting list mortality.  Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, Christophi C, Jones RM.

J Gastroenterol Hepatol. 2007 Jan;22(1):119-24. Erratum in: J Gastroenterol
Hepatol. 2007 Mar;22(3):457. PubMed PMID: 17201891.

​

CMV INFECTION AND ANTIVIRAL RESISTANCE IN A LIVER TRANSPLANT COHORT FOLLOWED LONGITUDINALLY: 1945  G. M. Scott, Z. Naing, J. Pavlovic, Z. M. Waliuzzaman, J. Iwasenko, N. Rismanto, P. Angus, R. Jones, W. Rawlinson

Transplantation 01/2010; 90. · 3.78 Impact Factor .

​

Risk Factors of Development of Gangrenous Cholecystitis and Its Treatment Outcomes .  Mehrdad Nikfarjam, Vachara Niumsawatt, Arun H. Sethu, Vijayaragavan Muralidharan, Michael A. Fink, Graham Starkey, Robert Jones, Christopher Christophi.   Gastroenterology 01/2011; 140(5). · 12.82 Impact Factor

 

Acute hepatitis B infection following blood transfusion.  Rode A, Jones R, Angus P, Brown D, Gow P.  Internal Medicine Journal, 41, 6, pp 509-510, MEDLINE with full text, EBSCOhost, viewed 30 July 2011.

 

Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis.   Mehrdad Nikfarjam, Vachara Niumsawatt, Arun Sethu, Michael A Fink, Vijayaragavan Muralidharan, Graham Starkey, Robert M Jones, Christopher Christophi .  HPB 08/2011; 13(8):551-8. · 1.94 Impact Factor.

 

Viral factors influencing the outcome of human cytomegalovirus infection in liver transplant recipients.  G M Scott, Z Naing, J Pavlovic, J M Iwasenko, P Angus, R Jones, W D Rawlinson .  Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 06/2011; 51(4):229-33. · 3.12 Impact Factor.

 

Acute hepatitis B infection following blood transfusion.   A P Rode, R M Jones, P W Angus, D Brown, P J Gow.  Internal Medicine Journal 06/2011; 41(6):509-10. · 1.82 Impact Factor.

​

Outcomes of patients with histologically proven acute acalculous cholecystitis.  Mehrdad Nikfarjam, Kiran Manya, Michael A Fink, Andrew K Hadj, Vijayaragavan Muralidharan, Graham Starkey, Robert M Jones, Christopher Christophi.  ANZ Journal of Surgery 09/2012; · 1.50 Impact Factor.

​

Early-onset versus late-onset nonanastomotic biliary strictures post liver transplantation: risk factors reflect different pathogenesis.  Jessica A Howell, Paul J Gow, Peter W Angus, Robert M Jones, Bao-Zhong Wang, Michael Bailey, Michael A Fink.  Transplant International 05/2012; 25(7):765-75. · 3.16 Impact.

 

Percutaneous Cholecystostomy for Treatment of Acute Cholecystitis in the Era of Early Laparoscopic Cholecystectomy.  Mehrdad Nikfarjam, Lilly Shen, Michael A Fink, Vijayaragavan Muralidharan, Graham Starkey, Robert M Jones, Christopher Christophi.  Surgical laparoscopy, endoscopy & percutaneous techniques 10/2013; 23(5):474-480. · 0.88 Impact Factor.

 

Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C. J Howell, R Sawhney, P Angus, M Fink, R Jones, B Z Wang, K Visvanathan, P Crowley, P Gow. Transplant Infectious Disease 09/2013; · 1.98 Impact Factor.

 

Outcomes of cholecystectomy for treatment of acute cholecystitis in octogenarians.

Mehrdad Nikfarjam, David Yeo, Marcos Perini, Michael A Fink, Vijayaragavan Muralidharan, Graham Starkey, Robert M Jones, Christopher Christophi.  ANZ Journal of Surgery 08/2013; · 1.50 Impact Factor.

​

Sex differences and outcomes of management of acute cholecystitis.

Mehrdad Nikfarjam, Efrant Harnaen, Farrukh Tufail, Vijayaragavan Muralidharan, Michael A Fink, Graham Starkey, Robert M Jones, Christopher Christophi

Surgical laparoscopy, endoscopy & percutaneous techniques 02/2013; 23(1):61-5. · 0.88 Impact Factor.

​

Pressurized Pulse Irrigation with Saline Reduces Surgical-site Infections following Major Hepatobiliary and Pancreatic Surgery: Randomized Controlled Trial. Mehrdad Nikfarjam, Laurence Weinberg, Michael A Fink, Vijayaragavan Muralidharan, Graham Starkey, Robert Jones, Kevin Staveley-O'Carroll, Christopher Christophi.  World Journal of Surgery 10/2013; · 2.23 Impact Factor .